HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toxic hepatitis in a case of Angelman syndrome associated with Lennox-Gastaut syndrome.

Abstract
We report a 26-month-old boy with Angelman syndrome associated with Lennox-Gastaut syndrome, who developed a rash and a persistent toxic hepatitis after lamotrigine was added to valproate therapy. The patient had typical findings of both Angelman and Lennox-Gastaut syndromes. Chromosome analysis performing by FISH analysis showed a deletion in chromosome 15 (q11.2 q11.2). Although some cases of Angelman syndrome associated with Lennox-Gastaut syndrome were reported in the literature, valproate and/or lamotrigine induced toxic hepatitis in Angelman syndrome has hitherto never been described. We conclude that VPA and LTG combination should be given with great caution or avoided in patients with Angelman syndrome.
AuthorsG Deda, H Caksen, A Kansu, N Girgin, E Suskan, S Uysal, A Tükün
JournalGenetic counseling (Geneva, Switzerland) (Genet Couns) Vol. 15 Issue 3 Pg. 357-61 ( 2004) ISSN: 1015-8146 [Print] Switzerland
PMID15517829 (Publication Type: Case Reports, Journal Article)
Topics
  • Angelman Syndrome (complications, genetics)
  • Chemical and Drug Induced Liver Injury (complications, genetics)
  • Child, Preschool
  • Chromosome Deletion
  • Chromosomes, Human, Pair 15 (genetics)
  • Epilepsy (classification, complications, genetics)
  • Humans
  • Male
  • Phenotype
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: